Skip to main content
Snerva

ARTICLE

The strongest OTC sleep aids, ranked honestly

Diphenhydramine is the most-purchased sleep aid in the United States. The Beers Criteria — the geriatric-medicine standard for medications older adults should not use — explicitly warns against it. Both facts are true at once. The first is louder than the second.

This is the cluster closer. It integrates the prior Snerva deep-dives on melatonin, magnesium, and CBD into a single ranked guide to the OTC sleep-aid aisle, plus the categories those deep-dives did not cover — diphenhydramine and the antihistamine class, the herbal supplements, the PM combination drugs, the proprietary blends, the GABA supplements that cannot reach the receptor printed on the bottle.

Four tiers, ordered by evidence and safety rather than by pharmacy end-cap economics. Tier 1 is what we recommend at the right dose for the right person. Tier 2 is the marginal and situational. Tier 3 is the OTC mainstream — most-purchased and mostly wrong. Tier 4 is the actively harmful, particularly with chronic use. The article closes with a use-case map so the reader at the pharmacy this week leaves with a verdict.

Snerva illustration — The strongest OTC sleep aids, ranked honestly
Marco Diversi
By Marco Diversi · Founder of SnervaPublished May 16, 2026

The pharmacy aisle is a category mistake

The sleep-aid section of a pharmacy is the worst place in the building to choose a sleep aid. Worth saying directly before the ranking begins.

The end-cap and the front-shelf positions are sold to manufacturers as marketing real estate. The products in those positions are not there because the pharmacist recommends them. They are there because the manufacturer paid for the slot, and the manufacturer paid for the slot because the product generates the margin the chain wants. The items that generate the most margin are the cheap-to-manufacture, heavily-branded ones — diphenhydramine PM formulations and the high-dose melatonin gummies. The items with the strongest evidence base for occasional, careful use — low-dose magnesium glycinate, L-theanine, glycine — sit in the supplement aisle or do not appear at all.

Snerva's ranking is built on evidence quality, safety profile, tolerance and dependence risk, regulatory quality of the product category, and practical cost-versus-benefit. The result is a four-tier ordering in which the items most consumers actually buy fall in the lower two tiers and the items we recommend sit on a shelf the store has not made easy to find.

The pharmacy end-cap is the worst place in the building to choose a sleep aid. The end-cap is sorted by margin, not by medicine.

How we ranked

Brief, because the criteria are the point and they are not subtle.

Five inputs. The quality of the published evidence — randomized trials, sample sizes, replication, effect sizes. The safety profile in both acute and chronic use. The tolerance and dependence trajectory over weeks and months. The regulatory quality of the product category in the United States and Europe — meaning how much you can trust the label. The practical cost-versus-benefit for a reader buying at standard retail.

We are not ranking by sales volume, by social-media virality, or by what a particular podcast host has recommended. The ranking is what we would tell a friend who walked into a pharmacy asking which one to pick. Several Tier 1 items are quietly excellent. Several Tier 3 items are excellent at being sold. The two lists do not overlap.

Tier 1 — Use with care, defensible for the right reader

Five entries. Modest effects, low risk, real evidence at the doses listed. None of these are sleep cures. All are reasonable additions to a sleep routine for the right indication.

Magnesium glycinate (200 to 400 milligrams, 60 to 90 minutes before bed)

The default Tier 1 entry. Modest effect on sleep onset, low side-effect profile, well-tolerated long-term. Form matters more than brand — glycinate is the form to default to; oxide is the cheap filler to avoid. Full version including dose-response, form ranking, and brand recommendations in our magnesium and sleep deep-dive.

L-theanine (200 milligrams, 30 to 60 minutes before bed)

Amino acid found in green tea. Mild anxiolytic effect, mediated through increased alpha brain wave activity and modest GABA modulation. Does not directly sedate. Best for sleep difficulty where mild bedtime anxiety is part of the picture rather than the whole picture. Pairs cleanly with magnesium glycinate — no interaction, complementary mechanisms. Reputable brands: Suntheanine (the patented form, used by most reputable third-party-tested products), Pure Encapsulations, NOW Foods.

Glycine (3 grams, 30 minutes before bed)

Amino acid. Mechanism: lowers core body temperature, which is itself a sleep-onset signal. Two Japanese randomized trials show improved subjective sleep quality and reduced next-day fatigue at three grams. Cheap, well-tolerated, no tolerance issues at standard doses. Notable: pairs synergistically with magnesium glycinate, which already provides some glycine — the combination is the cheapest reasonable Tier 1 sleep stack on the market.

Low-dose melatonin (0.3 to 0.5 milligrams) for circadian use cases only

Tier 1 only for the right indication: delayed sleep phase disorder, jet lag, shift work transitions. Tier 1 only at the right dose: 0.3 to 0.5 milligrams, not 3 to 10 milligrams. Tier 1 only at the right hour: four to six hours before target sleep, not at bedtime. Outside those parameters, melatonin slides into Tier 3. Full version in our melatonin deep-dive.

Apigenin (50 milligrams, 60 to 90 minutes before bed)

Flavonoid found in chamomile and parsley. Binds at the benzodiazepine site of GABA-A receptors with lower abuse potential than benzodiazepines themselves. The evidence base is emerging — small studies, mostly post-2020 — and the Andrew Huberman audience has amplified the recommendation faster than the literature has accumulated. Reasonable to try in the right context. Not yet the level of confidence we have for magnesium glycinate or glycine. Reputable brands: Double Wood, Pure Encapsulations.

Apigenin's evidence is real and thin. Huberman's audience is real and large. The first fact gets credit for the second's reach.

Tier 2 — Marginal, situational, not first choice

Modest evidence, mostly herbal, mostly tolerable. If one is part of a calming ritual you already enjoy, fine. None of them is the first place to start.

Valerian root (400 to 900 milligrams)

The oldest standby in the herbal sleep category. Meta-analyses show modest effects with high methodological heterogeneity. The smell is genuinely unpleasant, which limits compliance. If it works for you, it works. It is not the first recommendation for a reader who has not tried it.

Chamomile

The tea is pleasant and ritualistic and does what rituals do. The bioactive compound is apigenin, the same active in the Tier 1 apigenin recommendation. Supplements claiming chamomile extract for sleep are typically lower in apigenin per dose than the dedicated apigenin product. The tea is fine. The supplement is marketing.

Hops, passionflower, lemon balm

Mild GABA-ergic herbs with small studies showing small effects. Combination products claim synergy. The evidence for synergy is weak. The evidence for any individual herb in this group is modest. Reasonable to try; do not expect transformation.

Ashwagandha (300 to 600 milligrams)

Adaptogen with documented anxiolytic effects, including lowered evening cortisol. Improves sleep mostly via daytime stress reduction rather than direct sedation. Cycle the supplementation — eight weeks on, two weeks off — since long-term continuous use is less studied than the eight-week trial protocols suggest.

Tart cherry

Contains a small amount of natural melatonin — roughly 0.13 milligrams per eight ounces of juice. As food it is fine. As a supplement format priced ten times the active ingredient cost, it is overpriced low-dose melatonin sold by the gallon.

Tier 2 herbs are the rituals of better sleep. The tea works because of the tea. The leaves do less than the cup.

Tier 3 — Avoid for sleep

This is the section the cluster has been building toward. The OTC mainstream — the items most consumers actually buy — sits here. The reasons are pharmacology, not opinion.

Diphenhydramine (ZzzQuil, Tylenol PM, Benadryl as sleep aid)

First-generation antihistamine. The sleep effect is a side effect of its action on H1 histamine receptors, not a therapeutic design choice. Tolerance develops fast — most regular users find it stops working within three to seven days of nightly use. Strong anticholinergic activity produces dry mouth, constipation, urinary retention, blurred vision, and next-day cognitive fog. The half-life is four to eight hours, which leaves a measurable fraction of the dose in circulation through the next morning.

The cumulative-exposure risk is the larger concern. Gray and colleagues published in JAMA Internal Medicine in 2015 a longitudinal analysis showing that cumulative anticholinergic exposure correlates with elevated dementia incidence. The highest exposure tertile showed a hazard ratio of roughly 1.54. Subsequent replications have produced similar findings. The Beers Criteria — the standard reference for medications inappropriate in older adults — explicitly lists first-generation antihistamines as drugs to avoid in patients over sixty-five for routine sleep use. Diphenhydramine is the most-purchased sleep aid in the United States. Most of the purchasers do not know any of this.

Doxylamine (Unisom, NyQuil)

Same drug class as diphenhydramine, slightly less anticholinergic, half-life ten to twelve hours rather than four to eight. Same tolerance trajectory. Marginally less harmful but not meaningfully different in mechanism, risk profile, or appropriateness for chronic use. The longer half-life makes next-day grogginess worse, not better.

PM combination formulations (Tylenol PM, Advil PM, NyQuil)

Diphenhydramine stacked with acetaminophen, ibuprofen, or dextromethorphan. The therapeutic logic for the combination is weak — most users do not need a pain reliever every night. Chronic acetaminophen exposure carries hepatotoxicity risk at higher doses, which is the larger issue when the format is used nightly for years. Marketing convenience disguised as a sleep aid.

High-dose melatonin gummies (3 to 10 milligrams)

Wrong dose for the mechanism, wrong format for accuracy. Third-party testing has shown actual melatonin content in OTC gummies varies from seventeen percent to four hundred seventy-eight percent of the label claim. The product category exists because the format sells, not because the mechanism is sound. Full version in our melatonin deep-dive.

CBD products without a Certificate of Analysis

Twenty to forty percent of CBD products on the US market contain less CBD than the label claim. Five to fifteen percent contain detectable THC despite broad-spectrum or isolate labeling. Without a third-party Certificate of Analysis you can verify against the batch number on your bottle, you do not know what you bought. Full picture in our CBD and sleep piece.

Proprietary sleep-stack blends

These contain small amounts of multiple Tier 1 and Tier 2 ingredients without dose transparency. If the label reads "sleep blend, 500 milligrams" rather than listing individual ingredient doses, you cannot evaluate the product. Almost always under-dosed on the active ingredients that matter and over-priced for what is actually in the bottle.

The pharmacy-aisle sleep-aid section is a category mistake. The most-purchased item in it — diphenhydramine — is on the Beers Criteria list of medications older adults should not use. The second-most-purchased item — high-dose melatonin gummies — is the wrong dose of the wrong substance at the wrong time. Walk past the end-cap. The Tier 1 items live in the supplement section if at all, and they are not the items the store is paid to promote.

Anticholinergic burden is a cumulative number. The diphenhydramine you took every night for ten years adds up the same way the cigarettes did.

Tier 4 — Specifically harmful for chronic use

The Tier 3 items are inappropriate for chronic use. The Tier 4 items are inappropriate at any frequency past acute.

Chronic diphenhydramine

The cumulative anticholinergic burden is dose-dependent and exposure-time-dependent. Occasional use over a few weeks is one thing. Nightly use over years is the exposure profile most strongly associated with the dementia-risk signal. If you have been on diphenhydramine for sleep more than a month, the question is not whether to substitute. It is how quickly.

Alcohol as a sleep aid

Sedates fast, fragments the second half of the night, suppresses REM, builds tolerance in two to three weeks, becomes a dependence pattern in months. Universally recognized as bad sleep medicine and universally used as such. Full mechanism in our alcohol and sleep piece.

Oral GABA supplements

The GABA molecule itself does not cross the blood-brain barrier in any meaningful quantity, and the receptors it would act on are inside the brain. Labels claiming oral GABA reduces anxiety or improves sleep are claiming a pharmacological mechanism that does not occur. The category is mostly marketing. The money is better spent elsewhere.

PM stacked formulations long-term

Nightly diphenhydramine plus nightly acetaminophen for years is unstudied territory, and both constituents have documented chronic-exposure concerns. The combination format makes the chronic exposure invisible to the user — they think they are taking a sleep aid, not a hepatotoxin-adjacent painkiller stack.

How to actually pick — by use case

The synthesis. Six reader profiles, six recommendations.

Occasional bad night, travel, or jet lag

Low-dose melatonin, 0.3 to 0.5 milligrams, in the early evening at destination time. Magnesium glycinate as an optional adjunct if bedtime anxiety is part of the picture. For travel and circadian cases specifically, timed morning light resets the clock more reliably than any pill — a sunrise alarm or wake-up light is the on-brand device for anchoring the mornings melatonin alone cannot fix.

Anxiety-driven sleep onset

L-theanine at 200 milligrams plus magnesium glycinate at 300 milligrams, sixty minutes before bed. Consider a CBD trial — twenty-five milligrams sublingual, COA-backed brand — if no improvement after fourteen nights. The relevant clinical-condition piece is anxiety insomnia.

Muscle tension or restlessness at bedtime

Magnesium glycinate at 200 to 400 milligrams plus glycine at three grams, sixty to ninety minutes before bed. Cheap, well-tolerated, matched to the mechanism.

Persistent sleep problems for four or more weeks

Stop self-treating with OTC. The category is not built for this. Behavioral intervention is the right next step, and it carries the strongest evidence base in the field — our 6-week CBT-I program is the structured path through it. If you came here searching for a temazepam alternative or a prescription-strength sedative, the honest answer is a clinician, not a stronger pill — our online sleep doctor guide covers how to find one.

Older adult considering OTC sleep aids

Avoid diphenhydramine and doxylamine. Beers Criteria recommends against their use in this population, and the anticholinergic risk increases with age. Magnesium glycinate is the safer Tier 1 default. Discuss with a physician if sleep difficulty is persistent or new.

Already taking diphenhydramine nightly

Plan to stop. Substitute magnesium glycinate at 300 milligrams. Expect one to two weeks of adjustment — the antihistamine sedation will fade and the magnesium effect will build up. If you have been on diphenhydramine more than a year, taper rather than stopping abruptly: one night on, one off for a week, then off.

If your sleep stack costs more than fifty dollars a month, you are buying marketing. The Tier 1 items combined fit under twenty.

What to do this week

Three steps.

Audit your current sleep stack. Anything in Tier 3 or Tier 4 comes off the list — gradually if you have been using it nightly for more than a month, abruptly if it has been recent or intermittent. Diphenhydramine specifically: if you have been on it nightly for more than a year, taper the substitution rather than stopping cold.

Substitute with Tier 1 items where substitution is needed. Magnesium glycinate at 200 to 400 milligrams is the default substitute for general sleep onset. Add L-theanine at 200 milligrams if anxiety is part of the picture. Add glycine at three grams if onset is the dominant problem. For circadian indications, the protocol is in our melatonin deep-dive.

If sleep does not improve over fourteen nights of clean substitution, the issue is not at the OTC level. Behavioral intervention is the right next step, and its structured form is our 6-week CBT-I program — our insomnia hub covers the three patterns behind it. The OTC aisle is the wrong place to keep looking past that point.

Our treatments and substances hub is the parent piece — where this article and the rest of the cluster sit in the broader framework.

The deep-dive on the most-misused substance in the category, including dose, timing, and the third-party-testing supply problem, is melatonin.

The calibrated deep-dive on the cleanest Tier 1 item, including the form ranking and the dose protocol, is magnesium and sleep.

The honest read on the substance where the evidence is thin and the regulation thinner is CBD and sleep.

If the OTC aisle is the wrong category for your problem, the right next step is in the insomnia hub.

Where supplements fit, and do not, across the insomnia trajectory is in acute vs chronic insomnia.

The detailed comparison between behavioral and pharmacological approaches — including the prescription-versus-OTC line — is in CBT-I versus sleeping pills.

The Tier 4 substance most users do not realize is in Tier 4 is alcohol. The mechanism and the cost are in alcohol and sleep.

If the honest verdict is that no pill fits your case, the structured alternative is our 6-week CBT-I program — the evidence-based path the pharmacy aisle cannot sell.

The app-based versions of that treatment, compared honestly, are in best CBT-I online programs.

If you want a clinician — the real answer for anyone searching for a prescription-strength sedative or a temazepam alternative — start with our online sleep doctor and telehealth guide.

Frequently asked questions

Is ZzzQuil safe?

Safe for occasional acute use in adults under sixty-five. Not safe as a chronic nightly habit. The active ingredient is diphenhydramine, a first-generation antihistamine whose sleep effect is a side effect of its action on H1 receptors. Tolerance develops in days. Cumulative anticholinergic exposure correlates with elevated dementia risk in longitudinal data. For older adults specifically, the Beers Criteria recommends against its use for routine sleep. Find a better tool.

What is the best non-melatonin sleep aid?

For most adults, magnesium glycinate at 200 to 400 milligrams sixty to ninety minutes before bed is the cleanest Tier 1 starting point. If anxiety is part of the picture, add L-theanine at 200 milligrams. If onset is the dominant difficulty, add glycine at three grams. The combination of magnesium glycinate plus glycine is the cheapest reasonable sleep stack on the market — roughly twelve to fifteen dollars per month total.

Is Unisom safer than ZzzQuil?

Marginally. Unisom's active ingredient (doxylamine) has slightly less anticholinergic activity than ZzzQuil's diphenhydramine, but the half-life is longer (ten to twelve hours versus four to eight), which makes next-day grogginess worse. Same tolerance trajectory, same chronic-exposure concerns. Both are Tier 3 in this ranking. If you are choosing between the two, you are choosing between marginal versions of the same problem.

What about prescription sleep aids?

This article covers over-the-counter sleep aids. Prescription medications (Z-drugs, the orexin antagonists, doxepin at low doses, trazodone) are a separate conversation that involves a physician and a treatment plan. Our piece on CBT-I versus sleeping pills covers the broader comparison and the cases where prescription pharmacology is the appropriate next step.

Are sleep aids worth it at all?

For occasional acute situations — a single bad night, jet lag, a transient stressor — a well-chosen Tier 1 item is reasonable. For ongoing sleep difficulty past four weeks, OTC sleep aids are the wrong category to keep buying from. The evidence base for behavioral intervention (stimulus control, sleep restriction, full CBT-I) is meaningfully stronger than the evidence base for any OTC product. The aisle has its place. Its place is small.